Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Gold/Mining/Energy : IGT Pharma (V.IGT) Anti-Cancer Blockbuster!! -- Ignore unavailable to you. Want to Upgrade?

To: Solid Play who wrote (78)	8/30/1999 9:48:00 AM
From: Jeff Chan	Read Replies (1) \| Respond to of 86

I wish I could share your enthusiasm... The very fact that they've identified these compounds will probably not move the share price. Preclinical animal studies have to be performed and then the three human phases have to be completed. The investing public has also become much more skeptical of releases such as this and many biotech/startup pharmaceutical company share prices will not go up until phase III clinical trials have been completed and announcements of JV or joint marketing agreements have been made. ...not to pour water on you, but this is just the first step of a long road... Regards, Jeff C